Literature DB >> 11987131

Effect of mild acid pH on the functioning of bacterial membranes in Vibrio cholerae.

Florence Hommais1, Christine Laurent-Winter, Valérie Labas, Evelyne Krin, Christian Tendeng, Olga Soutourina, Antoine Danchin, Philippe Bertin.   

Abstract

In this paper, we initiated the first two-dimensional electrophoresis map of Vibrio cholerae, the aetiological agent of cholera disease. In this pathogen the efficient adaptation to detrimental conditions plays an important role in its survival in both the aquatic reservoir and human intestine. By proteome analysis we investigated the effect of mild acid treatment on the physiology of V. cholerae. More than 50 proteins were identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and database searching. Amongst them, pH regulated proteins belong to various functional classes such as intermediary metabolism and bacterial envelope. Several proteins whose accumulation level was decreased in response to acidic pH are known to be involved in the organization and the functioning of membranes, including lipopolysaccharide. Consistent with this, we observed an increased susceptibility to hydrophobic drugs, a loss of motility and a reduction in the ability to form a biofilm in cells grown at pH 6. Our results suggest that V. cholerae is able to sense a moderate decrease in pH and to modify accordingly its structure and physiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11987131     DOI: 10.1002/1615-9861(200205)2:5<571::AID-PROT571>3.0.CO;2-G

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

1.  Pleiotropic role of quorum-sensing autoinducer 2 in Photorhabdus luminescens.

Authors:  Evelyne Krin; Nesrine Chakroun; Evelyne Turlin; Alain Givaudan; François Gaboriau; Isabelle Bonne; Jean-Claude Rousselle; Lionel Frangeul; Céline Lacroix; Marie-Françoise Hullo; Laetitia Marisa; Antoine Danchin; Sylviane Derzelle
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

2.  Proteomic analysis of Vibrio cholerae in human stool.

Authors:  Regina C LaRocque; Bryan Krastins; Jason B Harris; Lauren M Lebrun; Kenneth C Parker; Michael Chase; Edward T Ryan; Firdausi Qadri; David Sarracino; Stephen B Calderwood
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

3.  Probiotics inspired from natural ecosystem to inhibit the growth of Vibrio spp. causing white gut syndrome in Litopenaeus vannamei.

Authors:  Abdulaziz Anas; Vrinda Sukumaran; Dhanraj Nampullipurackal Devarajan; Shijina Maniyath; Jasmin Chekidhenkuzhiyil; Ann Mary; Sreelakshmi Parakkaparambil Kuttan; Balu Tharakan
Journal:  3 Biotech       Date:  2021-01-12       Impact factor: 2.406

4.  The Vibrio cholerae VprA-VprB two-component system controls virulence through endotoxin modification.

Authors:  Carmen M Herrera; Alexander A Crofts; Jeremy C Henderson; S Cassandra Pingali; Bryan W Davies; M Stephen Trent
Journal:  MBio       Date:  2014-12-23       Impact factor: 7.867

5.  Prevalence, Antibiotic-Resistance, and Growth Profile of Vibrio spp. Isolated From Fish and Shellfish in Subtropical-Arid Area.

Authors:  Tarfa Abdalla; Hind Al-Rumaithi; Tareq M Osaili; Fayeza Hasan; Reyad S Obaid; Aisha Abushelaibi; Mutamed M Ayyash
Journal:  Front Microbiol       Date:  2022-04-06       Impact factor: 6.064

6.  Life in an arsenic-containing gold mine: genome and physiology of the autotrophic arsenite-oxidizing bacterium rhizobium sp. NT-26.

Authors:  Jérémy Andres; Florence Arsène-Ploetze; Valérie Barbe; Céline Brochier-Armanet; Jessica Cleiss-Arnold; Jean-Yves Coppée; Marie-Agnès Dillies; Lucie Geist; Aurélie Joublin; Sandrine Koechler; Florent Lassalle; Marie Marchal; Claudine Médigue; Daniel Muller; Xavier Nesme; Frédéric Plewniak; Caroline Proux; Martha Helena Ramírez-Bahena; Chantal Schenowitz; Odile Sismeiro; David Vallenet; Joanne M Santini; Philippe N Bertin
Journal:  Genome Biol Evol       Date:  2013       Impact factor: 3.416

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.